by John Bennett MD

We hosted a hangout with Shahriar Yaghoubi, Ph.D., MBA. Dr Yaghoubi has been doing pre-clinical and clinical research for over 20 years, now holding a position as CSO/Director of Clinical Research and Scientific Affairs/MSL at CellSight Technologies. The company develops molecular imaging technologies for cancer diagnostics and Dr Yaghoubi has been with the firm from the very beginning.

Shahriar says that cancer immunotherapy is a growing field, which, of couse, has not escaped the attention of Big Pharma.



No comments

Be the first one to leave a comment.

Post a Comment